LP220254-9
riTUXimab Ab
Active
Description
Rituximab antibodies are measured to detect and assess the development of antibodies against the therapeutic protein rituximab (tradenames Mabthera and Rituxan). The formation of anti-drug antibodies (ADA) against biopharmaceutical products can lead to loss of efficacy or potentially serious side effects. Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- riTUXimab Ab
- Part Display Name
- riTUXimab Ab
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-06-24
- Construct for LOINC Short Name
- riTUXimab Ab
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| fr-FR | French (France) | Rituximab anticorps |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://